As per the World Health Organization (WHO), it has been forecast that by 2050, the population of individuals at the age of 60 years or more than that is expected to increase to 2 billion from 900 million as per the 2015 data. It has been reported that the pace of ageing population is too high and is expanding at a dramatic rate. Aging population has higher prevalence of chronic diseases that is 6 in 10 older people have chronic diseases whereas, 4 in 10 adults suffer from chronic diseases. As the aging population will increase in the forecast period, different health issues related to aging will also increase in the upcoming years. Therefore, the demand for treatment of herpes will increase, driving the growth of the global herpes market.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-herpes-market
Data Bridge Market Research analyses that the herpes market is expected to grow at a CAGR of 6.6% in the forecast period of 2021 to 2028 and is expected to reach USD 1,627.74 million by 2029. Herpes API intermediates market needs great involvement of contract research organizations and contract manufacturing organizations to provide effective intermediates, which can cater to the needs of patients suffering from several kinds of chronic diseases. This signifies that increasing number of contract research organizations and contract manufacturing organizations is acting as an opportunity for the global herpes market growth.
Surge in Healthcare Expenditure globally is expected to drive the market's growth rate
People are getting more aware of their health and also there is alertness for preventive healthcare. Emphasis on healthcare is gaining popularity. The advanced technology available in healthcare system is helping manufacturers to produce novel anti-herpetic drugs, which are used for the treatment of various conditions of herpes and lead to higher survival rates. A developed health infrastructure guarantees strong and healthy manpower for providing healthcare services. It includes advanced machines and developed pharmaceutical industry. For instance, According to Centers for Medicare and Medicaid Services, in 2018, National Health Expenditures (NHE) rises by 4.6% to USD 3.60 trillion (USD 11,172 per person), which accounts for 17.7% of GDP. National health spending will reach to USD 6.20 trillion by 2028 with an average annual rate of 5.4% for 2019-2028. Improving and increasing healthcare infrastructure and expenditure will increase the process of installation of advanced technologies for the manufacturing of anti-herpetic drugs and APIs, which will enhance the product profile in the leading market, for this reason, increasing healthcare expenditure and infrastructure across the world is acting as an opportunity for boosting the demand of the global herpes market.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020(Customizable to 2014 - 2019)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Virus Type (Herpes Simplex and Herpes Zoster), Product (Acyclovir, Docosanol, Valacyclovir, Famciclovir and Others), Drug Type (Prescription Drug and Over-the-counter Drug), Age (Adult and Pediatrics), Route Of Administration (Topical, Oral, and Parenteral), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others), End Users (Hospitals, Speciality Clinics, and Others
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
Abbott (U.S.), Apotex, Inc. (Canada), Avet Pharmaceuticals, Inc. (U.S.), Bausch Health Companies, Inc. (Canada), Cipla, Inc. (India), Dr. Reddy’s Laboratories Ltd. (India), EPI Health (U.S.), Fresenius Kabi AG (Germany), GlaxoSmithKline plc.(U.K.), Glenmark Pharmaceutical Inc., (U.S.),, Maruho Co.,Ltd. (Japan), Mylan N.V. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Pharmaceuticals, Inc.(U.S.), RECORDATI S.p.A. (Italy), Aurobindo Pharma (India), Amneal Pharmaceuticals LLC(U.S.), Slavia Pharm S.R.L. (Romania), and Blistex, In (Canada)
|
Data Points Covered in Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
Global herpes market is categorized into seven notable segments based on the virus type, product, drug type, age, route of administration, distribution channel and end users.
The herpes simplex segment is expected to dominate the market growing with the highest CAGR of 6.6%
In 2021, the herpes simplex segment is expected to dominate the market growing with the highest CAGR of 6.6% in the forecast period of 2021 to 2028 due to the rise in prevalence of herpes infections because of having unprotected sex with an infected partner.
The hospital pharmacies segment is expected to dominate the market growing with the highest CAGR of 6.8%
In 2021, the hospital pharmacies segment is expected to dominate the market growing with the highest CAGR of 6.8% in the forecast period of 2021 to 2028 because of several major players in the market. The presence of major players boosts the market growth by launching new products in the market.
Major Players
Data Bridge Market Research recognizes the following companies as the major herpes market players in herpes market are Abbott (U.S.), Apotex, Inc. (Canada), Avet Pharmaceuticals, Inc. (U.S.), Bausch Health Companies, Inc. (Canada), Cipla, Inc. (India), Dr. Reddy’s Laboratories Ltd. (India), EPI Health (U.S.), Fresenius Kabi AG (Germany), GlaxoSmithKline plc.(U.K.), Glenmark Pharmaceutical Inc., (U.S.),, Maruho Co.,Ltd. (Japan), Mylan N.V. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Pharmaceuticals, Inc.(U.S.), RECORDATI S.p.A. (Italy), Aurobindo Pharma (India), Amneal Pharmaceuticals LLC(U.S.), Slavia Pharm S.R.L. (Romania), and Blistex, In (Canada).
Market Development
Regional Analysis
Geographically, the countries covered in the herpes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in herpes market during the forecast period
North America dominated the herpes market owing to the high number of increasing prevalence of herpes. North America will continue to dominate the herpes market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period due to the increasing healthcare expenditure.
Asia-Pacific is estimated to be the fastest-growing region in herpes market
Asia-Pacific is expected to grow during the forecast period due to the rising prevalence of geriatric population China, Japan, and India in this region. In addition, the growing presence of major market players and rising disposable income are expected to propel the market's growth rate in this region.
For more detailed information about the herpes market report, click here – https://www.databridgemarketresearch.com/reports/global-herpes-market
Global Herpes Market – Industry Trends and Forecast to 2028
Asia-Pacific Herpes Market – Industry Trends and Forecast to 2028
Middle East and Africa Herpes Market – Industry Trends and Forecast to 2028
Europe Herpes Market – Industry Trends and Forecast to 2028
North America Herpes Market – Industry Trends and Forecast to 2028